These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1990532

  • 1. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Kupiec-Weglinski JW, Hancock WW, Stunkel K, Diamantstein T, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract] [Full Text] [Related]

  • 2. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Sablinski T, Hancock WW, Mix CT, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract] [Full Text] [Related]

  • 3. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K, Tilney NL, Stunkel KG, Hancock WW, Diamantstein T, Kupiec-Weglinski JW.
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 5. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH, Hancock WW, Colby AJ, Padberg W, Diamantstein T, Kupiec-Weglinski JW, Tilney NL.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract] [Full Text] [Related]

  • 6. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW, Padberg W, Uhteg LC, Towpik E, Lord RH, Ma L, Diamantstein T, Strom TB, Tilney NL.
    Transplant Proc; 1987 Feb 01; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G, Dallman MJ, Morris PJ.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
    Kupiec-Weglinski JW, van der Meide P, Stunkel KG, Tanaka K, Diamantstein T, Tilney NL.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 1):992-3. PubMed ID: 2495637
    [No Abstract] [Full Text] [Related]

  • 11. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J, Jiang X, Huang Y, Zhang K, Xiao S, Yang C.
    Chin Med J (Engl); 2003 Mar 01; 116(3):432-5. PubMed ID: 12781053
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW, Di Stefano R, Stunkel KG, Grutzmann R, Theisen P, Araneda D, Tilney NL, Diamantstein T.
    Transplant Proc; 1988 Feb 01; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
    Diamantstein T, Mouzaki A, Osawa H, Volk HD, Hahn HJ, Kirkman RL, Strom TB, Tilney NL, Kupiec-Weglinski JW.
    Dev Biol Stand; 1988 Feb 01; 69():177-84. PubMed ID: 3066671
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 19. Functional blocking of the interleukin-2 receptor (IL-2R) may be important in the efficacy of IL-2R antibody therapy.
    Tellides G, Dallman MJ, Kupiec-Weglinski JW, Diamantstein T, Morris PJ.
    Transplant Proc; 1987 Oct 01; 19(5):4231-3. PubMed ID: 3118538
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.